Eric Small: This is one item for which there is bipartisan support
Eric Small, President of ASCO 2025-26, shared a post by ASCO, adding:
“This is one item for which there is bipartisan support. Let your elected Congress member know that you want them to support a comprehensive bill addressing this problem.”
Quoting ASCO‘s post:
“A new article in JCO Oncology Practice (JCO OP) looks at the root causes of cancer drug shortages in the U.S., the impact of these shortages on patients and providers, and makes recommendations to address this crisis.
The cancer community has been grappling with drug shortages since 2010, with periods of acute shortages such as in 2023. In just the last few years, around 15 cancer drugs have been in short supply.
A comprehensive approach, targeting the root causes of drug shortages, is needed to move the U.S. toward a future where people with cancer have consistent access to potentially life-saving care.”
Title: Crisis of Cancer Drug Shortages: Understanding the Causes and Proposing Sustainable Solutions
Authors: Jason Westin, Shimere Sherwood, Karen Hagerty, Julie Gralow
Read the Full Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023